Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Gastroenterology 135:194-204.e3
Use of institutional data warehouses, contributing 85% of cases, helped limit recall bias, though biological markers, including glycaemic indices, were unavailable, restricting mechanistic insight
GLP-1-based agents indicated for chronic weight management (semaglutide [Wegovy] and tirzepatide [Zepbound]) carry an FDA Boxed Warningthe agency's most serious safety alertregarding the risk of thyroid C-cell tumors
Noom provides ongoing coaching and behavioral strategies to help you transition off GLP-1 medications effectively, including gradual tapering plans and continued access to psychology-based tools
US$ 28.91
US$ 26.86
US$ 29.95
US$ 29.16
